021-51111890
购物车（0）
sales@molnova.cn
SACLAC
CAS No. 2248703-42-4
SACLAC ( —— )
产品货号. M37347 CAS No. 2248703-42-4
SACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥2519 | 有现货 |
|
| 5MG | ￥3900 | 有现货 |
|
| 10MG | ￥5588 | 有现货 |
|
| 25MG | ￥8446 | 有现货 |
|
| 50MG | ￥11652 | 有现货 |
|
| 100MG | ￥15071 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称SACLAC
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述SACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.
-
产品描述SACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Apoptosis
-
靶点Apoptosis
-
受体Apoptosis | Caspase
-
研究领域——
-
适应症——
化学信息
-
CAS Number2248703-42-4
-
分子量377.99
-
分子式C20H40ClNO3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES[C@H]([C@@H](CCCCCCCCCCCCCCC)O)(NC(CCl)=O)CO
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
Deferasirox (Fe3+ ch...
Deferasirox Fe3+ Chelate 是一种铁螯合剂，提取自专利 WO2003053986。
-
Puromycin aminonucle...
嘌呤霉素氨基核苷通过以氧化应激依赖性方式调节 ZO-1 来增加足细胞通透性。嘌呤霉素氨基核苷诱导的足细胞凋亡是 p53 依赖性的。嘌呤霉素氨基核苷以时间依赖性方式引起足细胞凋亡。
-
Etalocib
Etalocib 是一种新型二芳基醚羧酸衍生物，通过拮抗白三烯 B4 (LTB4) 受体或直接通过 5'-脂氧合酶，成为脂氧合酶途径的选择性且有效的抑制剂。
